Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Leaton is a brand of over-the-counter (OTC) dietary supplements developed by the Austrian pharmaceutical company Kwizda Pharma. The product line is formulated to provide a comprehensive blend of essential vitamins and minerals to support daily nutritional needs and address vitamin or mineral deficiencies. The standard formulation includes Vitamin A (Retinol Palmitate), a range of B-complex vitamins (B1, B2, B3, B5, B6, B12), Vitamin C (Ascorbic Acid), Vitamin D2 (Ergocalciferol), and Vitamin E (Alpha Tocopherol). These supplements are intended to promote physical and mental well-being by ensuring the body has the necessary cofactors for metabolic processes and immune function. While the Leaton line includes liquid tonics and syrups, it is also available in oral solid forms such as tablets or capsules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Leaton.